Dosage Forms

Articles

GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.

GlobalData Reports Need to Shift to Newer Vaccine Manufacturing Technologies

Fluarix Tetra has been approved for use in children aged six months and above.

GSK's Influenza Vaccine Gets EU Nod for Expanded Indication

The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.

GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program

Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.

New Immunotherapy for Pediatric Brain Cancer Targets Mutated Protein

Adrian Wildfire is project director, Infectious Diseases &Viral Challenge Unit, SGS Life SciencesâClinical Research.

Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states. 

Using Human Challenge Trials to Develop Flu Vaccines

Agnes Shanley is senior editor of Pharmaceutical Technology.

Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.

Making Vaccines Accessible

Amber Lowry is an associate editor at UBM plc.

This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.

Cold Chain: Delivering Vaccines to Patients

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The use of approved platform technologies can reduce the time and cost required to generate new vaccines.

Accelerating Vaccine Development and Manufacturing

The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.

Dynavax Wins FDA Approval for Hep B Vaccine

The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.  